Avances en el tratamiento farmacológico del dolor crónico. Opioides

Zech, 1995, Validation of WHO guidelines for cancer pain relief. A 10-year prospective study, Pain, 63, 65, 10.1016/0304-3959(95)00017-M Joranson, 2000, Trends in medical use and abuse of opioid analgesics, JAMA, 283, 1710, 10.1001/jama.283.13.1710 Simpson, 2004, Opioids for persistent non-cancer pain: recomendations for clinical practice, BJA, 92, 326, 10.1093/bja/aeh059 Allan, 2001, Randomized cossover trial of transdermal fentanyl and sustained release oral morphine for chronic non-cancer pain, BMJ., 322, 1, 10.1136/bmj.322.7295.1154 Bartleson, 2002, Evidence for and against the use of Opioid analgesics for chronic non malignant low back pain: a review, Pain Medicine, 3, 260, 10.1046/j.1526-4637.2002.02043.x Stitik, 2006, Pharmacotherapy of Osteoarthritis, Am J Phis Med Rehab, 85, S15, 10.1097/01.phm.0000245512.85085.a0 Cherny, 2001, Strategies to manage the adverse effects of oral morphine: an evidence-based report, J Clin Oncol, 19, 2542, 10.1200/JCO.2001.19.9.2542 Indelicato, 2002, Opioid rotation in the management of refractory cancer pain, J Clin Oncol, 20, 348, 10.1200/JCO.2002.20.1.348 Aliaga, 2002, Tratamiento del dolor. Teoría y práctica, Permanyer, 85 Collado, 1999, Farmacología de los opioides, Rev. Soc. Esp. Dolor, 6, 3 Contreras de la Fuente, 1999, Opioides orales en el dolor oncológico, Rev. Soc. Esp., 6, 28 2005, Quigley. The role of opioids in cancer pain, BMJ., 331, 825, 10.1136/bmj.331.7520.825 Snteularia, 1995, Fentanilo transdérmico. Una nueva opción terapéutica para el dolor neoplásico, Dolor, 10, 152 Herrera, 1999, Fentanilo transdérmico en el tratamiento del dolor crónico, Rev. Soc. Esp. Dolor, 6, 57 2006, Skaer. Transdermal opioids for cancer pain. Oncology, Pain Practice, 6, 225 Breivik, 2001, Opioids in cancer and chronic non cancer pain therapy. Indications and controversies, Act Anaesth Scand, 45, 1059, 10.1034/j.1399-6576.2001.450902.x Kosinski, 2005, An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with transdermal fentanyl, Pain Practice, 5, 378 Coluzzi, 2002, Dolor irruptivo en cáncer: ensayo aleatorizado comparativo entre citrato de fentanilo oral transmucosa (CFOT) y sulfato de morfina de liberación inmediata(MSIR), Rev. Soc. Esp. Dolor, 9, 306 Abad, 2002, Fentanilo oral transmucosa. Comité de evaluación de nuevos medicamentos, Osakidetza Torres, 2003, Uso, indicaciones y experiencia con Buprenorfina en parche transdérmico, Dolor, 18, 109 Aizpurua I, Ayerdi M, Fernández J et al. Buprenorfina transdérmica. Comité de evaluación de nuevos medicamentos, Osakidetza 2003; n° 76. Sanz, 2005, Oxicodona, Rev. Soc. Esp. Dolor, 12, 525 Maddocks, 1996, Atenuation of morphine induced delirium in palliative care by substitution with infusion of oxycodone, J Pain Sympton Manage, 12, 182, 10.1016/0885-3924(96)00050-4 Watson, 1998, Efficacy of oxicodone in neuropatic pain: a randomized trial in postherpeticneuralgia, Neurology, 50, 1837, 10.1212/WNL.50.6.1837 Lauretti, 2003, Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients, Br J Cancer, 89, 2027, 10.1038/sj.bjc.6601365